Israel, Canada, and the Netherlands are the only three countries in the world that have a government-sponsored cannabis research program. Researchers in Jerusalem, for example, were the first to discover the endocannabinoid system and the first to determine that the human brain produces its own cannabinoids. Since these discoveries, there has been a positive shift in the medical community toward cannabis, and the legalization of medical marijuana in certain U.S. states is a direct result of these discoveries. Although the United States has a booming $3 billion medical marijuana industry, it still outsources all of its medical marijuana research to Israel. Despite medical marijuana being legal in 23 states and Washington, DC, the DEA still classifies marijuana as a Schedule I narcotic, which makes conducting medical marijuana research extremely difficult and not worth the trouble. However, it is worth the trouble! Many influential researchers believe that cannabis can alleviate diseases and ailments such as schizophrenia, diabetes, cancer, eating disorders, Parkinson’s, Alzheimer’s and multiple sclerosis. However, researchers have not yet received the funding needed to perform human testing. Lets hope that with the public acceptance of cannabis, policies will shift, and the U.S. medical community will no longer have to outsource their medical marijuana research. Read the whole article on Newsweek here.
Comments will be approved before showing up.
Liquid error: Could not find asset snippets/mailchimp-popup.liquid